Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Nutrition & supportive carePRM 4620
Dosage formHard-gelatin capsules
Oral

5-Hydro Anthranilic Acid Hcl 0.2 mg, Biotin 30 mcg, Cholecalciferol 400 IU, Cyanocobalamin 2.5 mcg, DL-Methionine 18.4 mg, Folic Acid 0.50 mg, L-Arginine Hcl 13.28 mg, L-Histidine Hcl H2O 3.71 mg, L-Isoleucine 5.9 mg, L-Leucine 18.3 mg, L-Lysine Hcl 25 mg, L-Phenylalanine 5.0 mg, L-Threonine 4.2 mg, L-Tryptophan 5.0 mg, L-Valine 6.7 mg, Natural Betacarotene With Other Mixed Carotenoids 1000 mcg, Nicotinamide 25 mg, Pyridoxine Hcl 1.5 mg, Zinc Ascorbate 50 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Vitamin D / vitamin D analogue + Amino acid / metabolic nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2601
Dosage formTablets
Oral

Acetylcysteine 25 mg, Biotin 1 mg, Chromium 200 mcg, Cyanocobalamin 15 mcg, Folic Acid 1 mg, Glutamic Acid 25 mg, Glycerine 25 mg, Inositol 50 mg, Nicotinamide 50 mg, Pyridoxine Hcl 3 mg, Selenium 100 mcg, Vanadium 100 mcg, Zinc 20 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Mucolytic + Amino acid / metabolic nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2602
Dosage formTablets
Oral

Acetylcysteine 600 mg, L-5 Methylfolate Calcium 5.6 mg, Methylcobalamin 2 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Mucolytic + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2603
Dosage formTablets
Oral

Acetylcysteine 600 mg, L-5 Methyltetrahydrofolate Calcium 5.6 mg, Methylcobalamin 2 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Mucolytic + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 1666
Dosage formOral suspension
Oral

Activated Dimethicone 50 mg, Dried Aluminum Hydroxide Gel 250 mg, Magnesium Hydroxide 250 mg / 10 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2621
Dosage formTablets
Oral

Adenosylcobalamin 500 mcg, Folic Acid 5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2622
Dosage formTablets
Oral

Adenosylcobalamin 500 mcg, Folic Acid 5 mg, Methylcobalamin 500 mcg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2624
Dosage formTablets
Oral

Adenosylcobalamin 500 mcg, Methylcobalamin 500 mcg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2632
Dosage formTablets
Oral

ALA 100 mg, Benfotiamine 150 mg, Biotin 200 mcg, Calcium Carbonate 500 mg, Cr Picolinate 200 mcg, Folic Acid 1.5 mg, Inositol 100 mg, Methylcobalamin 1500 mcg, Pyridoxine 3 mg, Vit C 300 mg, Vit D3 2000 IU, Vit E 15 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Amino acid / metabolic nutritional supplement + Antioxidant / nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2639
Dosage formTablets
Oral

Alfacalcidol 0.25 mcg, Betacarotene Dispersion 10 mg, Calcium 500 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin D / vitamin D analogue + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2640
Dosage formTablets
Oral

Alfacalcidol 0.25 mcg, Calcium 200 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin D / vitamin D analogue + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2641
Dosage formTablets
Oral

Alfacalcidol 0.25 mcg, Calcium 500 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin D / vitamin D analogue + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2642
Dosage formTablets
Oral

Alfacalcidol 0.25 mcg, Calcium Citrate 1000 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin D / vitamin D analogue + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2643
Dosage formTablets
Oral

Alfacalcidol 0.25 mcg, Calcium Citrate 250 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin D / vitamin D analogue + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2644
Dosage formTablets
Oral

Alfacalcidol 0.25 mcg, Elemental Selenium 100 mcg, Elemental Zinc 7.5 mg, Folic Acid 1500 mcg, Inositol 100 mg, L-Arginine 500 mg, L-Carnitine L-Tartrate 50 mg, Piperine 2.5 mg, Ubidecarenone 10 mg, Vitamin B12 2.5 mcg, Vitamin B6 1.5 mg, Vitamin E 75 IU

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin D / vitamin D analogue + Amino acid / metabolic nutritional supplement + Antioxidant / nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2645
Dosage formTablets
Oral

Alfacalcidol 0.5 mcg, Biotin 1.0 mg, Chromium Picolinate 500 mcg, N-Acetyl L-Cysteine 600 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Mucolytic + Vitamin D / vitamin D analogue + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 5183
Dosage formSyrup
Oral

Aloe Vera, Amla, Carica Papaya, Giloy, Haritaki, Tulsi

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Polyherbal preparation
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 0089
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mcg, Calcium Picolinate 200 mg, Methylcobalamin 500 mcg, Pyridoxine 105 mg, Thiamine 2 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 4637
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 10 mg, Biotin 100 mcg, Folic Acid 1500 mcg, Methylcobalamin 1500 mcg, Pyridoxine Hcl 3 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Antioxidant / nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2668
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 100 mg, Folic Acid 1 mg, Inositol 100 mg, Methylcobalamin 750 mcg, Pyridoxine Hcl 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Amino acid / metabolic nutritional supplement + Antioxidant / nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2669
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 100 mg, Folic Acid 1.5 mg, Methylcobalamin 1000 mcg, Pyridoxine Hcl 3 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Antioxidant / nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 4638
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 100 mg, Folic Acid 5 mg, Inositol 100 mg, Methylcobalamin 1000 mcg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Amino acid / metabolic nutritional supplement + Antioxidant / nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 0090
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 100 mg, Inositol 100 mg, Methylcobalamin 750 mcg, Pyridoxine 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2670
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 100 mg, Methylcobalamin 0.5 mg, Pyridoxine 50 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Antioxidant / nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product